Selected research
Industry Research
Tumor Target Capture Platform Industry Research Report 2026
Market perspective
The global Tumor Target Capture Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Tumor Target Capture Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Tumor Target Capture Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Tumor Target Capture Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Tumor Target Capture Platform include Roche, Guardant Health, Illumina, Bio-Rad, Menarini Silicon Biosystems, GRAIL, Freenome, Angle and Exosome Diagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Tumor Target Capture Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Tumor Target Capture Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tumor Target Capture Platform Market by Company
Roche
Guardant Health
Illumina
Bio-Rad
Menarini Silicon Biosystems
GRAIL
Freenome
Angle
Exosome Diagnostics
Nanostring
Cell Microsystems
Vortex Biosciences
MagArray
Qiagen
Adaptive Biotechnologies
Mission Bio
Singleron
BGI
Amoy Diagnostics
GenoSaber
Annoroad
Genecast
Precision Scientific
Tumor Target Capture Platform Segment by Type
Immunoaffinity Capture Platform
Aptamer Capture Platform
Physical Separation Platform
Tumor Target Capture Platform Segment by Application
Clinical Diagnostics Industry
Laboratory Industry
Research and Higher Education Industry
Others
Tumor Target Capture Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Target Capture Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Target Capture Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Target Capture Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tumor Target Capture Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immunoaffinity Capture Platform
- Aptamer Capture Platform
- Physical Separation Platform
Applications
- Clinical Diagnostics Industry
- Laboratory Industry
- Research and Higher Education Industry
- Others
Companies covered
- Roche
- Guardant Health
- Illumina
- Bio-Rad
- Menarini Silicon Biosystems
- GRAIL
- Freenome
- Angle
- Exosome Diagnostics
- Nanostring
- Cell Microsystems
- Vortex Biosciences
- MagArray
- Qiagen
- Adaptive Biotechnologies
- Mission Bio
- Singleron
- BGI
- Amoy Diagnostics
- GenoSaber
- Annoroad
- Genecast
- Precision Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tumor Target Capture Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Immunoaffinity Capture Platform
- 2.2.3 Aptamer Capture Platform
- 2.2.4 Physical Separation Platform
- 2.3 Tumor Target Capture Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnostics Industry
- 2.3.3 Laboratory Industry
- 2.3.4 Research and Higher Education Industry
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Tumor Target Capture Platform Breakdown Data by Type
- 3.1 Global Tumor Target Capture Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Tumor Target Capture Platform Forecasted Market Size by Type (2027-2032)
4 Tumor Target Capture Platform Breakdown Data by Application
- 4.1 Global Tumor Target Capture Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Tumor Target Capture Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Tumor Target Capture Platform Market Perspective (2021-2032)
- 5.2 Global Tumor Target Capture Platform Growth Trends by Region
- 5.2.1 Global Tumor Target Capture Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Tumor Target Capture Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Tumor Target Capture Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Tumor Target Capture Platform Market Dynamics
- 5.3.1 Tumor Target Capture Platform Industry Trends
- 5.3.2 Tumor Target Capture Platform Market Drivers
- 5.3.3 Tumor Target Capture Platform Market Challenges
- 5.3.4 Tumor Target Capture Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Tumor Target Capture Platform Players by Revenue
- 6.1.1 Global Top Tumor Target Capture Platform Players by Revenue (2021-2026)
- 6.1.2 Global Tumor Target Capture Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Tumor Target Capture Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Tumor Target Capture Platform Head Office and Area Served
- 6.4 Global Tumor Target Capture Platform Players, Product Type & Application
- 6.5 Global Tumor Target Capture Platform Manufacturers Established Date
- 6.6 Global Tumor Target Capture Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Tumor Target Capture Platform Market Size (2021-2032)
- 7.2 North America Tumor Target Capture Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Tumor Target Capture Platform Market Size by Country (2021-2026)
- 7.4 North America Tumor Target Capture Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Tumor Target Capture Platform Market Size (2021-2032)
- 8.2 Europe Tumor Target Capture Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Tumor Target Capture Platform Market Size by Country (2021-2026)
- 8.4 Europe Tumor Target Capture Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Target Capture Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Tumor Target Capture Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Tumor Target Capture Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Tumor Target Capture Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Tumor Target Capture Platform Market Size (2021-2032)
- 10.2 South America Tumor Target Capture Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Tumor Target Capture Platform Market Size by Country (2021-2026)
- 10.4 South America Tumor Target Capture Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Target Capture Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Tumor Target Capture Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Tumor Target Capture Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Tumor Target Capture Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.1.4 Roche Tumor Target Capture Platform Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Guardant Health
- 12.2.1 Guardant Health Company Information
- 12.2.2 Guardant Health Business Overview
- 12.2.3 Guardant Health Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.2.4 Guardant Health Tumor Target Capture Platform Product Portfolio
- 12.2.5 Guardant Health Recent Developments
- 12.3 Illumina
- 12.3.1 Illumina Company Information
- 12.3.2 Illumina Business Overview
- 12.3.3 Illumina Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.3.4 Illumina Tumor Target Capture Platform Product Portfolio
- 12.3.5 Illumina Recent Developments
- 12.4 Bio-Rad
- 12.4.1 Bio-Rad Company Information
- 12.4.2 Bio-Rad Business Overview
- 12.4.3 Bio-Rad Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.4.4 Bio-Rad Tumor Target Capture Platform Product Portfolio
- 12.4.5 Bio-Rad Recent Developments
- 12.5 Menarini Silicon Biosystems
- 12.5.1 Menarini Silicon Biosystems Company Information
- 12.5.2 Menarini Silicon Biosystems Business Overview
- 12.5.3 Menarini Silicon Biosystems Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.5.4 Menarini Silicon Biosystems Tumor Target Capture Platform Product Portfolio
- 12.5.5 Menarini Silicon Biosystems Recent Developments
- 12.6 GRAIL
- 12.6.1 GRAIL Company Information
- 12.6.2 GRAIL Business Overview
- 12.6.3 GRAIL Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.6.4 GRAIL Tumor Target Capture Platform Product Portfolio
- 12.6.5 GRAIL Recent Developments
- 12.7 Freenome
- 12.7.1 Freenome Company Information
- 12.7.2 Freenome Business Overview
- 12.7.3 Freenome Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.7.4 Freenome Tumor Target Capture Platform Product Portfolio
- 12.7.5 Freenome Recent Developments
- 12.8 Angle
- 12.8.1 Angle Company Information
- 12.8.2 Angle Business Overview
- 12.8.3 Angle Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.8.4 Angle Tumor Target Capture Platform Product Portfolio
- 12.8.5 Angle Recent Developments
- 12.9 Exosome Diagnostics
- 12.9.1 Exosome Diagnostics Company Information
- 12.9.2 Exosome Diagnostics Business Overview
- 12.9.3 Exosome Diagnostics Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.9.4 Exosome Diagnostics Tumor Target Capture Platform Product Portfolio
- 12.9.5 Exosome Diagnostics Recent Developments
- 12.10 Nanostring
- 12.10.1 Nanostring Company Information
- 12.10.2 Nanostring Business Overview
- 12.10.3 Nanostring Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.10.4 Nanostring Tumor Target Capture Platform Product Portfolio
- 12.10.5 Nanostring Recent Developments
- 12.11 Cell Microsystems
- 12.11.1 Cell Microsystems Company Information
- 12.11.2 Cell Microsystems Business Overview
- 12.11.3 Cell Microsystems Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.11.4 Cell Microsystems Tumor Target Capture Platform Product Portfolio
- 12.11.5 Cell Microsystems Recent Developments
- 12.12 Vortex Biosciences
- 12.12.1 Vortex Biosciences Company Information
- 12.12.2 Vortex Biosciences Business Overview
- 12.12.3 Vortex Biosciences Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.12.4 Vortex Biosciences Tumor Target Capture Platform Product Portfolio
- 12.12.5 Vortex Biosciences Recent Developments
- 12.13 MagArray
- 12.13.1 MagArray Company Information
- 12.13.2 MagArray Business Overview
- 12.13.3 MagArray Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.13.4 MagArray Tumor Target Capture Platform Product Portfolio
- 12.13.5 MagArray Recent Developments
- 12.14 Qiagen
- 12.14.1 Qiagen Company Information
- 12.14.2 Qiagen Business Overview
- 12.14.3 Qiagen Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.14.4 Qiagen Tumor Target Capture Platform Product Portfolio
- 12.14.5 Qiagen Recent Developments
- 12.15 Adaptive Biotechnologies
- 12.15.1 Adaptive Biotechnologies Company Information
- 12.15.2 Adaptive Biotechnologies Business Overview
- 12.15.3 Adaptive Biotechnologies Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.15.4 Adaptive Biotechnologies Tumor Target Capture Platform Product Portfolio
- 12.15.5 Adaptive Biotechnologies Recent Developments
- 12.16 Mission Bio
- 12.16.1 Mission Bio Company Information
- 12.16.2 Mission Bio Business Overview
- 12.16.3 Mission Bio Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.16.4 Mission Bio Tumor Target Capture Platform Product Portfolio
- 12.16.5 Mission Bio Recent Developments
- 12.17 Singleron
- 12.17.1 Singleron Company Information
- 12.17.2 Singleron Business Overview
- 12.17.3 Singleron Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.17.4 Singleron Tumor Target Capture Platform Product Portfolio
- 12.17.5 Singleron Recent Developments
- 12.18 BGI
- 12.18.1 BGI Company Information
- 12.18.2 BGI Business Overview
- 12.18.3 BGI Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.18.4 BGI Tumor Target Capture Platform Product Portfolio
- 12.18.5 BGI Recent Developments
- 12.19 Amoy Diagnostics
- 12.19.1 Amoy Diagnostics Company Information
- 12.19.2 Amoy Diagnostics Business Overview
- 12.19.3 Amoy Diagnostics Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.19.4 Amoy Diagnostics Tumor Target Capture Platform Product Portfolio
- 12.19.5 Amoy Diagnostics Recent Developments
- 12.20 GenoSaber
- 12.20.1 GenoSaber Company Information
- 12.20.2 GenoSaber Business Overview
- 12.20.3 GenoSaber Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.20.4 GenoSaber Tumor Target Capture Platform Product Portfolio
- 12.20.5 GenoSaber Recent Developments
- 12.21 Annoroad
- 12.21.1 Annoroad Company Information
- 12.21.2 Annoroad Business Overview
- 12.21.3 Annoroad Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.21.4 Annoroad Tumor Target Capture Platform Product Portfolio
- 12.21.5 Annoroad Recent Developments
- 12.22 Genecast
- 12.22.1 Genecast Company Information
- 12.22.2 Genecast Business Overview
- 12.22.3 Genecast Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.22.4 Genecast Tumor Target Capture Platform Product Portfolio
- 12.22.5 Genecast Recent Developments
- 12.23 Precision Scientific
- 12.23.1 Precision Scientific Company Information
- 12.23.2 Precision Scientific Business Overview
- 12.23.3 Precision Scientific Revenue in Tumor Target Capture Platform Business (2021-2026)
- 12.23.4 Precision Scientific Tumor Target Capture Platform Product Portfolio
- 12.23.5 Precision Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst